JACOBS & CO/CA - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS & CO/CA ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$287
+0.7%
2,8250.0%0.04%
+5.9%
Q2 2023$285
+10.0%
2,8250.0%0.03%
+6.2%
Q1 2023$259
+1.2%
2,8250.0%0.03%
-3.0%
Q4 2022$256
-99.9%
2,8250.0%0.03%
+6.5%
Q3 2022$214,000
-10.1%
2,8250.0%0.03%
-3.1%
Q2 2022$238,000
-37.2%
2,825
-34.7%
0.03%
-23.8%
Q1 2022$379,000
-18.5%
4,325
-18.8%
0.04%
-12.5%
Q4 2021$465,000
+6.9%
5,3250.0%0.05%
-4.0%
Q3 2021$435,000
-10.3%
5,3250.0%0.05%
-10.7%
Q2 2021$485,000
+20.3%
5,325
+12.7%
0.06%
+14.3%
Q1 2021$403,000
-9.6%
4,7250.0%0.05%
-15.5%
Q4 2020$446,000
+8.8%
4,7250.0%0.06%
-1.7%
Q3 2020$410,000
-0.5%
4,7250.0%0.06%
-11.9%
Q2 2020$412,000
+5.9%
4,7250.0%0.07%
-10.7%
Q1 2020$389,000
-13.0%
4,7250.0%0.08%
+10.3%
Q4 2019$447,000
+59.6%
4,725
+46.5%
0.07%
+51.1%
Q3 2019$280,000
-4.8%
3,2250.0%0.04%
-4.3%
Q2 2019$294,000
-5.2%
3,2250.0%0.05%
-11.3%
Q1 2019$310,000
+4.0%
3,225
-7.2%
0.05%
-10.2%
Q4 2018$298,000
-0.3%
3,4750.0%0.06%
+15.7%
Q3 2018$299,000
+14.1%
3,4750.0%0.05%
+8.5%
Q2 2018$262,000
-6.4%
3,4750.0%0.05%
-9.6%
Q1 2018$280,000
-3.8%
3,4750.0%0.05%
-1.9%
Q4 2017$291,000
-2.3%
3,4750.0%0.05%
-5.4%
Q3 2017$298,000
-10.0%
3,475
-12.6%
0.06%
-13.8%
Q2 2017$331,000
+5.8%
3,975
-5.9%
0.06%
+1.6%
Q1 2017$313,000
-17.6%
4,225
-19.1%
0.06%
-22.0%
Q4 2016$380,000
-15.2%
5,225
-8.0%
0.08%
-18.0%
Q3 2016$448,000
-4.3%
5,6800.0%0.10%
-9.1%
Q2 2016$468,000
+13.9%
5,6800.0%0.11%
+11.1%
Q1 2016$411,000
-12.0%
5,6800.0%0.10%
-18.2%
Q4 2015$467,000
-16.6%
5,680
-6.9%
0.12%
-18.8%
Q3 2015$560,000
-13.7%
6,100
-7.6%
0.15%
-8.0%
Q2 2015$649,000
-14.9%
6,600
-14.8%
0.16%
-16.1%
Q1 2015$763,000
+2.7%
7,745
-3.4%
0.19%
-1.5%
Q4 2014$743,000
-1.6%
8,0200.0%0.20%
-8.4%
Q3 2014$755,000
+4.0%
8,0200.0%0.21%
+1.9%
Q2 2014$726,000
+0.7%
8,020
-5.4%
0.21%
-6.2%
Q1 2014$721,000
+20.0%
8,480
+13.4%
0.22%
+16.7%
Q4 2013$601,000
+4.9%
7,4800.0%0.19%
-3.5%
Q3 2013$573,000
-6.5%
7,480
-13.8%
0.20%
-10.4%
Q2 2013$613,0008,6800.22%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders